Sensient Technologies
SXT
132.00
-0.91
-0.68%
Sensient Technologies
US · SXT
#2027 by market cap
Listed 1970
132.00
-0.91
-0.68%
Live - 5344 symbols - heartbeat 468s ago
· 2026-10-07 19:54
After-hours
132.00
0.00%
- Market cap
- 5.62B
- P/E (TTM)i
- 35.58
- P/Bi
- 4.46
- EPSi
- 3.16
- Div yieldi
- 1.24%
- 52W posi
- 88%
Reader sentiment
Are you bullish or bearish on SXT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.82, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.52% YoY
Margins
- Gross margin
- 33.45%
- Operating margin
- 12.85%
- Net margin
- 8.34%
Key ratios & quality
- Enterprise valuei
- 6.29B
- Altman Z-Scorei
- 5.82
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.39B | 1.32B | 1.33B | 1.38B | 1.44B | 1.46B | 1.56B | 1.61B |
| Gross profit | 466.13M | 414.87M | 423.75M | 454.66M | 489.11M | 460.30M | 507.09M | 539.30M |
| Selling & admin expenses | 262.75M | 293.76M | 271.09M | 284.63M | 292.36M | 305.27M | 315.51M | 332.17M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 203.38M | 121.11M | 152.66M | 170.03M | 196.75M | 155.02M | 191.58M | 207.13M |
| Pretax profit | 181.53M | 101.00M | 137.85M | 157.48M | 182.20M | 129.85M | 162.80M | 177.55M |
| Tax | 24.17M | 18.96M | 28.37M | 38.74M | 41.32M | 36.46M | 38.13M | 43.06M |
| Net profit | 157.36M | 82.05M | 109.47M | 118.75M | 140.89M | 93.39M | 124.67M | 134.49M |
| Basic EPS | 4 | 2 | 3 | 3 | 3 | 2 | 3 | 3 |
| Diluted EPS | 3.70 | 1.94 | 2.59 | 2.81 | 3.34 | 2.21 | 2.94 | 3.16 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 392.33M | 414.23M | 412.11M | 393.45M | 435.83M | 462.08M |
| Gross profit | 131.78M | 142.83M | 141.34M | 123.35M | 152.69M | 172.80M |
| Selling & admin expenses | 78.25M | 85.13M | 83.64M | 85.16M | 85.96M | 96.10M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 53.53M | 57.71M | 57.71M | 38.19M | 66.73M | 76.70M |
| Pretax profit | 46.19M | 50.32M | 50.38M | 30.67M | 58.83M | 68.53M |
| Tax | 11.73M | 12.73M | 13.42M | 5.18M | 14.66M | 17.17M |
| Net profit | 34.46M | 37.59M | 36.96M | 25.48M | 44.17M | 51.36M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.81 | 0.88 | 0.87 | 0.60 | 1.04 | 1.20 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 822.87M | 788.21M | 741.59M | 741.15M | 934.78M | 936.62M | 961.89M | 1.08B |
| Cash & ST investments | 31.90M | 21.15M | 24.77M | 25.74M | 20.92M | 28.93M | 26.63M | 36.53M |
| Inventory | 490.76M | 422.52M | 381.35M | 411.64M | 564.11M | 598.40M | 600.30M | 678.22M |
| Total assets | 1.82B | 1.74B | 1.74B | 1.75B | 1.98B | 2.01B | 2.02B | 2.24B |
| Total current liabilities | 214.70M | 201.38M | 215.96M | 232.31M | 272.15M | 236.31M | 270.64M | 263.58M |
| Short-term debt | 20.05M | 20.61M | 9.25M | 8.54M | 20.37M | 13.46M | 19.85M | 352.00K |
| Long-term debt | 689.55M | 598.50M | 518.00M | 503.01M | 630.33M | 645.09M | 613.52M | 709.23M |
| Total liabilities | 964,993,000.00 | 858,562,000.00 | 806,524,000.00 | 807,068,000.00 | 982,016,000.00 | 961,183,000.00 | 962,808,000.00 | 1,050,623,000.00 |
| Total equity | 859.95M | 881.59M | 934.34M | 938.43M | 999.60M | 1.05B | 1.06B | 1.19B |
| Retained earnings | 1.52B | 1.54B | 1.58B | 1.63B | 1.70B | 1.73B | 1.78B | 1.85B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.00B | 1.07B | 1.07B | 1.08B | 1.12B | 1.18B |
| Cash & ST investments | 32.57M | 56.69M | 42.67M | 36.53M | 38.54M | 31.02M |
| Inventory | 598.20M | 619.60M | 653.72M | 678.22M | 681.73M | 719.09M |
| Total assets | 2.09B | 2.20B | 2.21B | 2.24B | 2.29B | 2.37B |
| Total current liabilities | 230.70M | 251.12M | 233.69M | 263.58M | 223.71M | 269.62M |
| Short-term debt | 18.58M | 26.28M | 777.00K | 352.00K | 232.00K | 397.00K |
| Long-term debt | 683.27M | 710.12M | 711.18M | 709.23M | 767.56M | 763.50M |
| Total liabilities | 997,634,000.00 | 1,047,440,000.00 | 1,029,380,000.00 | 1,050,623,000.00 | 1,068,707,000.00 | 1,111,175,000.00 |
| Total equity | 1.10B | 1.16B | 1.18B | 1.19B | 1.22B | 1.26B |
| Retained earnings | 1.80B | 1.82B | 1.84B | 1.85B | 1.87B | 1.91B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 83.52M | 177.18M | 218.78M | 145.22M | 12.07M | 169.70M | 157.15M | 127.83M |
| Depreciation & amortization | 53.24M | 55.02M | 49.64M | 52.05M | 52.47M | 57.82M | 60.33M | 61.10M |
| Free cash flow | 32.78M | 138.08M | 166.62M | 84.43M | -67.25M | 81.83M | 97.94M | 38.42M |
| Dividends paid | -57.41M | -62.19M | -66.06M | -66.69M | -68.92M | -69.22M | -69.40M | -69.61M |
| Stock buybacks / issuance | -76.73M | 0 | 0 | -42.51M | -- | -- | -- | -- |
| Ending cash balance | 31.90M | 21.15M | 24.77M | 25.74M | 20.92M | 28.93M | 26.63M | 36.53M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -8.98M | 48.28M | 43.96M | 44.56M | -13.62M | 48.46M |
| Depreciation & amortization | 15.07M | 15.26M | 15.56M | 15.21M | 15.54M | 15.89M |
| Free cash flow | -25.83M | 27.10M | 24.21M | 12.94M | -42.35M | 9.69M |
| Dividends paid | -17.38M | -17.32M | -17.50M | -17.42M | -17.43M | -17.44M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 32.57M | 56.69M | 42.67M | 36.53M | 38.54M | 31.02M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 18.38 | 9.42 | 12.06 | 12.68 | 14.54 | 9.10 | 11.79 | 11.93 |
| ROA %i | 8.87 | 4.60 | 6.29 | 6.81 | 7.56 | 4.67 | 6.17 | 6.30 |
| ROIC %i | 11.58 | 6.41 | 8.19 | 8.81 | 9.81 | 6.63 | 8.61 | 8.72 |
| 5-year avg ROE %i | 12.35 | 12.95 | 13.10 | 12.63 | 13.42 | 11.56 | 12.03 | 12.01 |
| EBIT margin %i | 14.67 | 9.15 | 11.46 | 12.32 | 13.69 | 10.64 | 12.30 | 12.85 |
| FCF / sales %i | 2.36 | 10.44 | 12.51 | 6.12 | -- | 5.62 | 6.29 | 2.38 |
| Current ratioi | 3.83 | 3.91 | 3.43 | 3.19 | 3.43 | 3.96 | 3.55 | 4.10 |
| Quick ratioi | 1.34 | 1.16 | 1.20 | 1.23 | 1.19 | 1.27 | 1.17 | 1.30 |
| Debt / assetsi | 38.88 | 35.58 | 30.29 | 29.31 | 32.84 | 32.69 | 31.30 | 31.62 |
| LT debt / equityi | 80.19 | 67.89 | 55.44 | 53.60 | 63.06 | 61.24 | 57.83 | 59.42 |
| Interest coveragei | 9.31 | 6.02 | 10.31 | 13.55 | 13.53 | 6.16 | 6.66 | 7.00 |
| Revenue CAGR (3Y) %i | 0.26 | -1.47 | -0.75 | -0.16 | 2.80 | 3.02 | 4.10 | 3.91 |
| Net income CAGR (3Y) %i | 13.80 | -13.38 | 6.91 | -8.96 | 19.75 | -5.16 | 1.64 | -1.54 |
| FCF CAGR (3Y) %i | -12.00 | 10.47 | -- | 37.08 | -- | -21.10 | 5.07 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.87 | 12.18 | 12.31 | 11.93 | 12.46 | 13.07 |
| ROA %i | 6.26 | 6.42 | 6.54 | 6.30 | 6.58 | 6.90 |
| ROIC %i | 8.55 | 8.69 | 8.89 | 8.72 | 8.83 | 9.26 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.51 | 12.93 | 13.22 | 12.85 | 13.31 | 14.05 |
| FCF / sales %i | 4.35 | 4.01 | 1.49 | 2.38 | 1.32 | 0.26 |
| Current ratioi | 4.34 | 4.25 | 4.59 | 4.10 | 5.01 | 4.39 |
| Quick ratioi | 1.51 | 1.56 | 1.57 | 1.30 | 1.70 | 1.51 |
| Debt / assetsi | 33.54 | 33.40 | 32.22 | 31.62 | 33.56 | 32.22 |
| LT debt / equityi | 62.40 | 61.37 | 60.26 | 59.42 | 62.97 | 60.60 |
| Interest coveragei | 6.73 | 7.07 | 7.42 | 7.00 | 7.31 | 7.74 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Color is the largest reported line at 46.77% of revenue, across 4 reported segments.
- Flavors & Extracts follows at 46.13%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Color46.77%
Flavors & Extracts46.13%
Asia Pacific10.30%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.